$Enliven Treateutics(ELVN)$ $Terns Pharmaceuticals, Inc.(TERN)$ $Kura Oncology(KURA)$ I’m watching a classic biotech squeeze unfold in Enliven Therapeutics $ELVN. Shares just ripped +44% to fresh 52 week highs after early Phase 1b leukemia data for ELVN-001 surprised to the upside. What matters here is context. Even after today’s vertical move, the stock is only about +2.5% y/y, which tells me this is a sentiment reset, not a late-stage blow off. A long period of dead money met with credible data is exactly how violent re-ratings start. Volume confirms it, momentum traders are pressing, and shorts are scrambling to reprice risk. This is how broken charts turn into crowded trades fast.
💊 ⓗⓐⓟⓟⓨ ⓣⓡⓐⓓⓘⓝⓖ ⓐⓗⓔⓐⓓ! ⓒⓗⓔⓔⓡⓢ, ⓑⓒ🍀🍀🍀
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?